Related Experiment Videos
Glomerulocystic kidney. A hypothesis of origin and pathogenesis
Archives of Pathology & Laboratory Medicine
|September 1, 1977
Insights
Phenacetin use during pregnancy may lead to glomerulocystic kidney disease in infants. This condition involves dilation of Bowman
Area of Science:
- Nephrology
- Pediatric Pathology
- Teratology
Background:
- Glomerulocystic kidney disease (GCKD) is a severe congenital renal disorder.
- It is characterized by cystic dilation of Bowman's space and glomeruli.
- GCKD primarily affects infants and can lead to end-stage renal disease.
Observation:
- A case report of an infant diagnosed with glomerulocystic kidney disease.
- Maternal history revealed regular phenacetin use during the second half of pregnancy.
- The infant presented with characteristic renal morphologic features of GCKD.
Findings:
- The study suggests a potential link between maternal phenacetin exposure and GCKD pathogenesis.
- Renal morphologic features in the patient align with those described in literature for GCKD.
- Medullary obstruction is proposed as a contributing factor to the development of this renal lesion.
Implications:
- This finding highlights the potential teratogenic effects of phenacetin on fetal kidney development.
- It underscores the importance of evaluating maternal medication history in cases of congenital kidney diseases.
- Further research is warranted to elucidate the precise mechanisms by which phenacetin may induce medullary obstruction and GCKD.
Abstract:
Glomerulocystic kidney, a disease primarily of infants, is characterized by dilation of Bowman's space. We describe an infant whose mother had regularly taken phenacetin during the latter half of her pregnancy. This history, with the renal morphologic features of our patient and those described in the literature, suggests that medullary obstruction contributes to the pathogenesis of this lesion.